Matthew L. Danielson

Computer-aided drug design platform using PyMOL

Markus A. Lill, Matthew L. Danielson · Journal of Computer-Aided Molecular Design · 2010 · 636 citations

Pharmacy, Medicinal Chemistry, Biomolecular Modeling +10

Long-chain carboxychromanols, metabolites of vitamin E, are potent inhibitors of cyclooxygenases

Qing Jiang, Xinmin Yin, Markus A. Lill et al. · Proceedings of the National Academy of Sciences · 2008 · 180 citations · Full text

Life Sciences, Biochemistry, Pharmacology +16

Evaluation of Short-term and Long-term Complications after Emergent Internal Iliac Artery Embolization in Patients with Pelvic Trauma

Talitha Travis, Wayne L. Monsky, Jason A. London et al. · Journal of Vascular and Interventional Radiology · 2008 · 100 citations

Medicine, Surgery, Vascular Surgery +13

Potentially increasing the metabolic stability of drug candidates via computational site of metabolism prediction by CYP2C9: The utility of incorporating protein flexibility via an ensemble of structures

Matthew L. Danielson, Prashant Desai, Michael A. Mohutsky et al. · European Journal of Medicinal Chemistry · 2011 · 27 citations

Pharmacy, Bioinformatics, Pharmacology +17

In Silico and in Vitro Assessment of OATP1B1 Inhibition in Drug Discovery

Matthew L. Danielson, Geri A. Sawada, Thomas J. Raub et al. · Molecular Pharmaceutics · 2018 · 17 citations

Pharmacy, Pharmacokinetics, Pharmacology +15